Ginger.io has recently added $20 million in Series B funding from Kaiser Permanente Ventures, bringing the total amount raised up to $28.2 million.
According to the SEC filing, the behavioral health analytics startup added Kaiser Permanente Ventures partner Dave Schulte to its board, indicating who led the round. Ginger.io’s earlier investors include Romulus Capital, Khosla Ventures and True Ventures.
Kaiser is already a Ginger.io partner, with this funding likely to get the two companies even closer together, helping the startup become more widely used in hospitals.
Aside from Kaiser, Ginger.io has also partnered with other medical institutions, such as UCSF, Massachusetts General Hospital, Brigham and Women’s Hospital, McLean Hospital, Duke University, UC Davis and University of Nebraska Medical Center. The company has recently launched a grant-funded program to help low-income people suffering from depression in Utah.